-
Objective to improve imaging recognition of infantile polycystic kidney disease (IPKD).
目的提高对婴儿型多囊肾(IPKD)的影像学认识。
-
The PKD Foundation is the only organization, worldwide, dedicated to fighting polycystic kidney disease (PKD).
美国多囊肾疾病基金会是唯一面向国际多囊肾病人的非营利慈善组织。
-
Objective To develop a method for detecting the mutations in autosomal dominant polycystic kidney disease gene 2(PKD2) and detect the mutations of PKD2 in Chinese.
目的建立检测2型常染色体显性遗传性多囊肾病致病基因PKD2突变的方法,分析中国汉族人PKD2基因的突变。
-
This patient had dominant polycystic kidney disease (DPKD).
这个患者有显性多囊肾(DPKD)。
-
In both rats and humans, polycystic kidney disease severely reduces the output of urine, preventing the kidneys from being able to rid the body of toxins.
不论在大鼠还是人类,多囊性肾病严重降低尿液排出量,抑制肾脏排出体内毒素的能力。
多囊肾又名Potter(Ⅰ)综合征、Perlmann综合征、先天性肾囊肿瘤病、囊胞肾、双侧肾发育不全综合征、肾脏良性多房性囊瘤、多囊病。我国1941年朱宪彝首先报道,本病临床并不少见。多囊肾有两种类型,常染色体隐性遗传型(婴儿型)多囊肾,发病于婴儿期,临床较罕见;常染色体显性遗传型(成年型)多囊肾,常于青中年时期被发现,也可在任何年龄发病。